Uterine Fibroid Embolization
UFE is a safe, minimally invasive, image-guided procedure to treat symptoms of uterine fibroids.
Dr. Azher Iqbal has more than 20 years experience performing this procedure. He is the first physician in WNY to perform outpatient UFE via radial (wrist) artery approach, thereby reducing risk of infection, bleeding, and prolonged bed rest.
Fibroid tumors are benign (noncancerous) growths in the uterine wall. Their size ranges from very tiny to very large. In some cases, they can cause the uterus to grow to the size of a five-month pregnancy or more.
During this procedure, a tiny puncture is made in the skin of the wrist or groin and a catheter (small tube) is inserted into an artery. The catheter is then guided through the artery to the uterus using a live X-ray (fluoroscopy). Tiny particles (the size of grains of sand) are released into the artery that is supplying blood to the fibroid, thus cutting off blood flow to the fibroid. This results in eventual shrinkage of fibroids. The procedure is performed while the patient is conscious but sedated. Patient is released home the same day after a few hours of observation. Many women are able to return to normal activities within one week.
I recently had the uterine fibroid embolization performed by Dr. Azher Iqbal at Buffalo Vascular Care. It has been made apparent by both Dr. Iqbal and his staff’s actions that the patient is number one. Clearly, this is a highly professional, friendly, efficient team that works cohesively for the total well being of the patient.
– Suzanne P
Symptoms caused by Uterine Fibroids
- Heavy, prolonged menstrual periods and unusual monthly bleeding, sometimes with clots
- Pelvic pain, pressure or heaviness
- Back pain
- Pain during sexual intercourse
- Bladder pressure and frequent urge to urinateConstipation and bloating
- Enlarged abdomen
Uterine fibroids are very common. 20 to 40 percent of women over the age of 35 have uterine fibroids of a significant size. African-American women are at higher risk for fibroids and as many as 50 percent have symptomatic fibroids.